Farmaprojects S.A.U.
PolandAll drugs from this manufacturer
-
The medicine is intended for adult patients with active psoriatic arthritis, moderate to severe chronic plaque psoriasis, and Behçet's disease (for the treatment of oral ulcers).
Dosage form: tablets, film-coated
Active substance Dosage apremilast 10 mg or 20 mg or 30 mg ATC: L04AA32
-
The medicine is used in adult patients with active psoriatic arthritis, moderate to severe chronic plaque psoriasis, and for the treatment of oral ulcers in patients with Behçet's disease.
Dosage form: tablets, film-coated
Active substance Dosage apremilast 30 mg ATC: L04AA32
-
It is an antibiotic used in adults and adolescents over 12 years of age to treat infections such as pneumonia or bronchitis, throat and sinus infections, and skin and soft tissue infections.
Dosage form: tablets, film-coated, prolonged release
Active substance Dosage clarithromycin 500 mg ATC: J01FA09
-
The medicine is used to reduce high blood sugar levels in adults with type 2 diabetes. It helps increase insulin levels after meals and limits the amount of sugar produced by the body.
Dosage form: tablets, film-coated
Active substance Dosage sitagliptin hydrochloride monohydrate 108.96 mg ATC: A10BH01
-
The medicine is used to reduce high blood sugar levels in adults with type 2 diabetes. It may be taken alone or together with other medicines that lower blood sugar.
Dosage form: tablets, film-coated
Active substance Dosage sitagliptin hydrochloride monohydrate 27.24 mg ATC: A10BH01
-
The medicine is used to reduce high blood sugar levels in adults with type 2 diabetes. It helps increase insulin levels after meals and limits the amount of sugar produced by the body.
Dosage form: tablets, film-coated
Active substance Dosage sitagliptin hydrochloride monohydrate 54.48 mg ATC: A10BH01
-
The medicine is used in adults to reduce the risk of another heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 2.5 mg ATC: B01AF01
-
The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery and to treat deep vein thrombosis and pulmonary embolism (and to prevent their recurrence).
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg ATC: B01AF01
-
In adults, it is used to prevent strokes and other blood clots (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg ATC: B01AF01
-
It is used in adults to treat deep vein thrombosis (in the legs) and pulmonary embolism, as well as to prevent the recurrence of blood clots in the blood vessels of the legs and lungs.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg or 20 mg ATC: B01AF01
-
The medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat clots after initial injectable treatment.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg ATC: B01AF01